Brand New Medical Study
Potential New Treatment for Migraines
💡 Open in NSW, VIC, SA and QLD
📝 Registration Form
If you take part in the research study you will receive:
Reimbursement of costs
For out-of-pocket expenses, such as travel and meals.
Free study-related medical care
You may gain access to new research treatments, before they are widely available.
No overnight stays!
All study visits are out-patient only.
🏥 Study Guide
Who can take part in this study?
In order to be considered to take part in the study, you’ll need to meet all of the following:
- You are between the ages of 18 and 70 inclusively
- You have had frequent migraines for at least 1 year
- You have tried migraine treatments to prevent your migraines, which had no effect on them
Who is unable take part in this study?
- Anyone who suffers from a chronic illness
- Anyone who uses barbiturates or opioids to treat their migraines more than 4 days per month
- People who have used botox injections within the last 3 months
- Anyone who has tried a ketogenic diet, low-carb diet or intermittent fasting, within the last 3 months
How long will the study take?
If you agree to take part, and the study is suitable for you, your participation in the study is expected to last up to 17 weeks. This includes:
- A screening period of up to 2 weeks
- A 4-week baseline measurement period
- A 12-week treatment period
- A final 1-week safety follow-up period
What is the purpose of this study?
There is still much we don’t know about what causes migraines, nor how to treat them effectively. Some research suggests that a ketogenic (high-fat and low-carbohydrate) diet helps to prevent migraines.
This study aims to test the effectiveness of a drug which includes a ketogenic substance, in reducing symptoms of patients who frequently experience migraines. The study is randomised and eligible participants may receive the study drug, or a placebo.
Where is my nearest study site?
Here is a map of all of the sites who are currently recruiting for this study:
What if I have other questions about the study?
We are here for you! Click or tap this button to send an email to our Patient Experience team: